Summit Therapeutics
SMMT
#2244
Rank
ยฃ6.08 B
Marketcap
ยฃ7.61
Share price
-5.87%
Change (1 day)
-38.49%
Change (1 year)

EPS for Summit Therapeutics (SMMT)

EPS in 2026 (TTM): -ยฃ0.80

According to Summit Therapeutics 's latest financial reports the company's current EPS (TTM) is -ยฃ0.82. In 2025 the company made an earnings per share (EPS) of -ยฃ1.11.

EPS history for Summit Therapeutics from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ0.80-27.47%
2025-ยฃ1.11
2021-ยฃ0.7326.32%
2020-ยฃ0.58
2018-ยฃ0.03318-84.63%
2017-ยฃ0.22-40.59%
2016-ยฃ0.366.54%
2015-ยฃ0.34

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sarepta Therapeutics
SRPT
-ยฃ2.01 145.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
ยฃ10.59-1,395.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
-ยฃ0.79-3.74%๐Ÿ‡บ๐Ÿ‡ธ USA